AMN
AMN HEALTHCARE SERVICES INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 28 ▲ Three major passive institutional investors, Wells Fargo, Schwab, an…
- Jun 15 ▼ 1 insider sell $114.4K at $31.07
- Aug 6 AMN Healthcare reported Q2 2026 adjusted EPS of $0.77, massively bea…
- Nov 5 AMN Healthcare reported Q3 2026 revenue of $717M (+13% YoY) and adju…
- Nov 5 ▲ Earnings: AMN Q3 2026 Earnings: EPS $1.16 (+399.4% vs est)
- Nov 5 ▼ AMN Healthcare reported Q3 2026 revenue of $717M (13% YoY growth) an…
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $114.4K.
- InstitutionsBULLISH
Q3 2026: 31 added (0 new), 19 trimmed or exited.
- AnalystsMIXED
6 of 13 rate it Buy or better. Median target $45.00 (+14%).
- Short sellersSTEADY
Short interest +11.5% to 4.27M shares. 3.9 days to cover, ≈11.1% of shares.
- TrendUPTREND
2% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | ADD | $61.0M |
| Boston Partners | TRIM | $42.5M |
| UBS Group AG | TRIM | $16.9M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | $15.6M |
| MACKENZIE FINANCIAL CORP | ADD | $14.6M |
| First Eagle Investment Management, LLC | ADD | $14.1M |
| Empowered Funds, LLC | DOUBLED | $13.5M |
| FEDERATED HERMES, INC. | TRIM | $11.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
13 analystsPrice is inside the target range. Median implies +14%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | Truist Securities MAINTAIN | Buy |
| Nov 6, 2026 | Citizens MAINTAIN | Market Outperform |
| Oct 9, 2026 | BMO Capital MAINTAIN | Outperform |
| Sep 11, 2026 | BMO Capital MAINTAIN | Outperform |
| Aug 14, 2026 | Citizens MAINTAIN | Market Outperform |
| Aug 7, 2026 | UBS MAINTAIN | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Laughlin Whitney M Chief Legal Officer Oct 15, 2026 | EXERCISE | 4,976 sh |
Laughlin Whitney M Chief Legal Officer Oct 15, 2026 | TAX W/H | $45.6K |
Hagan Mark Christopher Chief Information and Digital Oct 15, 2026 | EXERCISE | 9,331 sh |
Hagan Mark Christopher Chief Information and Digital Oct 15, 2026 | TAX W/H | $126.1K |
Laughlin Whitney M Chief Legal Officer Sep 15, 2026 | EXERCISE | 498 sh |
Laughlin Whitney M Chief Legal Officer Sep 15, 2026 | TAX W/H | $4.2K |
FOLETTA MARK G Director Jun 15, 2026 | SELL | $52.2K |
FOLETTA MARK G Director Jun 15, 2026 | SELL | $62.1K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
11 filings · 2 bullish · 1 bearish · 3 mixed · 5 neutral- NEUTRAL SC 13GNov 16, 2026
Ameriprise Financial disclosed a 5.0% passive stake in AMN Healthcare via Schedule 13G, representing 1,939,466 shares as of September 30, 2026. This is a new filing by Ameriprise, not an amendment, and certifies no intent to influence control.
🔒 Fresh report (last 24h), subscribers only
- MIXED 8-KNov 5, 2026
AMN Healthcare reported Q3 2026 revenue of $717M (+13% YoY) and adjusted EPS of $1.16, both well…
The sharp Q4 guidance decline is almost entirely due to the expected collapse in labor disruption revenue ($5M vs $124M in Q4 2025). Excluding labor disruption, Nurse and Allied Solutions segment…
- BEARISH PRESS-RELEASENov 5, 2026
AMN Healthcare reported Q3 2026 revenue of $717M (13% YoY growth) and adjusted EPS of $1.16…
The Q3 beat is overshadowed by the Q4 guidance collapse driven by the normalization of labor disruption revenue. Monitor whether the core nurse and allied staffing business (excluding disruptions)…
- NEUTRAL INST-CLUSTEROct 29, 2026
Three asset managers doubled or added to AMN positions in Q3 2026, with aggregate buying of $2.4M…
The cluster is small and stale (45-day lag). Monitor next 13F for continuation or reversal. The absence of insider buying reduces conviction.
All AMN filing & press-release reports (11)
- SC 13G reportNov 16, 2026
- 8-K reportNov 5, 2026
- PRESS-RELEASE reportNov 5, 2026
- INST-CLUSTER reportOct 29, 2026
- INST-CLUSTER reportAug 12, 2026
- PRESS-RELEASE reportAug 6, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportMay 4, 2026
- PRESS-RELEASE reportApr 9, 2026
- DEFA14A reportMar 18, 2026
- INST-CLUSTER reportFeb 28, 2026